Net income
|
27,020,000 |
31,913,000 |
31,274,000 |
42,024,000 |
36,139,000 |
|
Depreciation and amortization
|
11,654,000 |
9,576,000 |
10,358,000 |
9,766,000 |
6,997,000 |
|
Accretion of acquired loans
|
(5,338,000) |
(4,925,000) |
(2,338,000) |
(1,373,000) |
(522,000) |
|
Provision for loan losses
|
(1,000,000) |
2,900,000 |
2,950,000 |
1,100,000 |
2,450,000 |
|
Deferred income tax expense (benefit)
|
4,412,000 |
(812,000) |
831,000 |
(372,000) |
NA
|
|
Stock-based compensation expense
|
684,000 |
1,459,000 |
1,981,000 |
2,410,000 |
2,199,000 |
|
Stock grants to directors for retainer fee
|
403,000 |
327,000 |
363,000 |
441,000 |
375,000 |
|
Proceeds from sales of mortgage loans held for sale
|
120,880,000 |
114,757,000 |
111,311,000 |
101,146,000 |
163,056,000 |
|
Origination of mortgage loans held for sale
|
(116,997,000) |
(110,778,000) |
(108,857,000) |
(96,179,000) |
(169,661,000) |
|
Net gain from sales of mortgage loans held for sale
|
(3,626,000) |
(3,699,000) |
(3,972,000) |
(3,536,000) |
(5,032,000) |
|
Gain on trust preferred securities repurchase
|
0 |
(2,970,000) |
0 |
0 |
NA
|
|
Net gain from sales and valuation write-downs of foreclosed assets
|
(62,000) |
(520,000) |
(319,000) |
(169,000) |
(132,000) |
|
Net gain from sales and valuation write-downs of former bank premises
|
0 |
35,000 |
133,000 |
(78,000) |
(559,000) |
|
Net loss from sales and write-downs of fixed assets
|
55,000 |
174,000 |
71,000 |
134,000 |
5,000 |
|
Net (gain) loss from sales of available for sale securities
|
(17,000) |
1,000 |
(37,000) |
0 |
NA
|
|
Earnings on bank owned life insurance
|
(1,113,000) |
(1,264,000) |
(2,731,000) |
(1,287,000) |
(3,567,000) |
|
Net change in
|
Accrued interest receivable
|
(321,000) |
122,000 |
(1,056,000) |
(1,126,000) |
(609,000) |
|
Other assets
|
(4,815,000) |
(648,000) |
(354,000) |
(2,193,000) |
(7,163,000) |
|
Accrued interest payable and other liabilities
|
4,185,000 |
(1,046,000) |
(943,000) |
11,029,000 |
(3,843,000) |
|
Net cash from operating activities
|
36,004,000 |
34,602,000 |
38,665,000 |
61,737,000 |
20,133,000 |
|
Loan originations and payments, net
|
(188,932,000) |
(97,282,000) |
(178,373,000) |
(193,556,000) |
(168,412,000) |
|
Purchases of securities available for sale
|
(10,645,000) |
(164,336,000) |
(67,027,000) |
(48,664,000) |
(53,353,000) |
|
Proceeds from maturities, calls and repayments of securities available for sale
|
93,873,000 |
172,173,000 |
52,504,000 |
40,308,000 |
60,617,000 |
|
Proceeds from sales of securities available for sale
|
1,483,000 |
264,000 |
7,619,000 |
0 |
NA
|
|
Proceeds from sales of foreclosed assets
|
2,967,000 |
2,059,000 |
993,000 |
772,000 |
632,000 |
|
Proceeds from sales of former bank premises
|
0 |
45,000 |
25,000 |
1,964,000 |
854,000 |
|
Purchases of Federal Home Loan Bank stock
|
0 |
(459,000) |
(3,010,000) |
(4,986,000) |
(1,980,000) |
|
Proceeds from Federal Home Loan Bank stock redemption
|
6,132,000 |
NA
|
NA
|
NA
|
NA
|
|
Purchases of bank owned life insurance
|
0 |
(7,000,000) |
(1,500,000) |
0 |
(2,500,000) |
|
Proceeds from bank owned life insurance cash value release and death benefits
|
0 |
0 |
2,720,000 |
0 |
7,708,000 |
|
Net purchases of premises and equipment
|
(1,081,000) |
(2,025,000) |
(5,423,000) |
(6,318,000) |
(9,109,000) |
|
Net cash for investing activities
|
(96,203,000) |
(96,561,000) |
(191,472,000) |
(210,480,000) |
(165,543,000) |
|
Net increase (decrease) in time deposits
|
(147,106,000) |
(20,854,000) |
(55,839,000) |
(30,091,000) |
196,035,000 |
|
Net increase in all other deposits
|
146,944,000 |
120,457,000 |
203,219,000 |
(28,566,000) |
107,348,000 |
|
Net increase (decrease) in securities sold under agreements to repurchase
|
(12,798,000) |
(23,061,000) |
(12,962,000) |
(15,229,000) |
471,000 |
|
Maturities of Federal Home Loan Bank advances
|
(6,000,000) |
(3,000,000) |
(45,000,000) |
(30,000,000) |
(30,000,000) |
|
Proceeds from Federal Home Loan Bank advances
|
20,000,000 |
110,000,000 |
90,000,000 |
160,000,000 |
44,000,000 |
|
Proceeds from stock option exercises
|
891,000 |
978,000 |
318,000 |
108,000 |
16,000 |
|
Employee stock purchase plan
|
44,000 |
36,000 |
46,000 |
52,000 |
39,000 |
|
Dividend reinvestment plan
|
655,000 |
1,601,000 |
1,576,000 |
1,165,000 |
541,000 |
|
Repurchases of common stock shares
|
(15,762,000) |
(3,732,000) |
0 |
(5,943,000) |
(7,110,000) |
|
Repurchase of trust preferred securities
|
0 |
(8,030,000) |
0 |
0 |
NA
|
|
Payment of cash dividends to common shareholders
|
(9,516,000) |
(18,731,000) |
(12,046,000) |
(27,500,000) |
(12,746,000) |
|
Net cash from (for) financing activities
|
(22,648,000) |
155,664,000 |
169,312,000 |
23,996,000 |
298,594,000 |
|
Net change in cash and cash equivalents
|
(82,847,000) |
93,705,000 |
16,505,000 |
(124,747,000) |
153,184,000 |
|
Cash and cash equivalents at beginning of period
|
172,738,000 |
89,891,000 |
183,596,000 |
200,101,000 |
75,354,000 |
|
Cash and cash equivalents at end of period
|
89,891,000 |
183,596,000 |
200,101,000 |
75,354,000 |
228,538,000 |
|
Interest
|
11,618,000 |
12,477,000 |
15,468,000 |
21,569,000 |
23,361,000 |
|
Federal income tax
|
8,000,000 |
15,125,000 |
14,225,000 |
10,075,000 |
8,875,000 |
|
Transfers from loans to foreclosed assets
|
2,203,000 |
414,000 |
887,000 |
744,000 |
227,000 |
|
Transfers from bank premises to other real estate owned
|
0 |
381,000 |
1,736,000 |
296,000 |
0 |
|